Cargando…
Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation
BACKGROUND: The standard treatment of stage III N2 small cell lung cancer (SCLC) is concurrent chemoradiation, and surgery is not recommended. This study was aimed to evaluate whether surgery has survival benefits in patients with stage III N2 SCLC and investigate the factors influencing survival of...
Autores principales: | Chai, Yanfei, Ma, Yuchao, Feng, Wei, Lu, Hongwei, Jin, Longyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404296/ https://www.ncbi.nlm.nih.gov/pubmed/34461929 http://dx.doi.org/10.1186/s12957-021-02364-6 |
Ejemplares similares
-
Outcome of Non-small Cell Lung Cancer Patients With N3 Stage: Survival Analysis of Propensity Score Matching With a Validated Predictive Nomogram
por: Han, Chang, et al.
Publicado: (2021) -
Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database
por: Zhang, Shengchao, et al.
Publicado: (2023) -
Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma
por: Zhu, Qianjun, et al.
Publicado: (2023) -
Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018) -
Propensity‐score matching with competing risks in survival analysis
por: Austin, Peter C., et al.
Publicado: (2018)